Name: Briobacept Biosimilar, Research Grade
SKU: ARP-B01222
Availability: InStock

Brentuximab Biosimilar, Research Grade

Catalog # : ARP-B00592

Target : CD30Lreceptor, Ki-1antigen, CD30, TNFRSF8, D1S166E, Tumornecrosisfactorreceptorsuperfamilymember8, LymphocyteactivationantigenCD30

Reactivity : Human

From $349.00

See Details

Briakinumab Biosimilar - Research Grade

Catalog # : ICH5188

Target : CD30

Applications : FA

From $355.00

See Details

Briakinumab Biosimilar - Research Grade: APC

Catalog # : ICH5188APC

Target : CD30

Applications : FA

From $305.00

See Details

Briakinumab Biosimilar - Research Grade: Biotin

Catalog # : ICH5188B

Target : CD30

Applications : FA

From $405.00

See Details

Briakinumab Biosimilar - Research Grade: Dylight®488

Catalog # : ICH5188D488

Target : CD30

Applications : FA

Reactivity : Human

From $405.00

See Details

Briakinumab Biosimilar - Research Grade: HRP

Catalog # : ICH5188HRP

Target : CD30

Applications : FA

From $405.00

See Details

Briakinumab Biosimilar - Research Grade: PE

Catalog # : ICH5188PE

Target : CD30

Applications : FA

From $305.00

See Details

Briakinumab Biosimilar, Research Grade

Catalog # : ARP-B00011

Target : IL-12subunitp40, IL12B, Interleukin-12subunitbeta, IL-12B, CLMFp40, NKSF2, NKcellstimulatoryfactorchain2, Cytotoxiclymphocytematurationfactor40kDasubunit

Reactivity : Human

From $349.00

See Details

Briakinumab ELISA Kit

Catalog # : ARP-BS-401

Sensitivity : 33.12 ng/mL

Detection Range : 78.125 - 5,000 ng/mL

From $1,199.00

See Details

Briobacept Biosimilar, Research Grade

Catalog # : ARP-B01222

Target : BAFF, ZTNF4, BLYS, Tumornecrosisfactorligandsuperfamilymember13B, Dendriticcell-derivedTNF-likemolecule, TALL-1, TNF-andAPOL-relatedleukocyteexpressedligand1, BLyS, Blymphocytestimulator, TNFSF13B, CD257, TNFSF20, TALL1, B-cell-activatingfactor

Reactivity : Human

From $479.00

See Details

Biosimilar Antibodies

Information

Customer Service

Our Partners

Biosimilar Antibodies

Categories